AFG
LMAT icon

Albion Financial Group’s LeMaitre Vascular LMAT Stock Holding History

Albion Financial Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,624
Closed -$213K – 757
2025
Q4 		$213K Sell
2,624
-94
-3% -$8.09K 0.01% 168
2025
Q3 		$238K Sell
2,718
-11
-0.4% -$982 0.01% 165
2025
Q2 		$227K Hold
2,729
– – 0.01% 164
2025
Q1 		$229K Sell
2,729
-1,067
-28% -$99.3K 0.02% 171
2024
Q4 		$350K Buy
3,796
+204
+6% +$19.6K 0.02% 152
2024
Q3 		$334K Sell
3,592
-82
-2% -$7.11K 0.02% 153
2024
Q2 		$302K Sell
3,674
-300
-8% -$22K 0.02% 162
2024
Q1 		$264K Buy
3,974
+212
+6% +$13.1K 0.02% 164
2023
Q4 		$214K Sell
3,762
-50
-1% -$2.62K 0.02% 179
2023
Q3 		$208K Buy
3,812
+30
+0.8% +$1.78K 0.02% 161
2023
Q2 		$254K Buy
3,782
+10
+0.3% +$610 0.02% 164
2023
Q1 		$194K Buy
3,772
+180
+5% +$8.74K 0.02% 161
2022
Q4 		$165K Hold
3,592
– – 0.02% 168
2022
Q3 		$182K Buy
3,592
+245
+7% +$12.2K 0.02% 163
2022
Q2 		$152K Sell
3,347
-1,064
-24% -$47.6K 0.02% 180
2022
Q1 		$205K Buy
4,411
+420
+11% +$18.8K 0.02% 196
2021
Q4 		$200K Sell
3,991
-139
-3% -$7.19K 0.02% 212
2021
Q3 		$219K Buy
4,130
+4
+0.1% +$225 0.02% 180
2021
Q2 		$252K Buy
+4,126
New +$219K 0.02% 170
2020
Q4 		$167K Sell
4,121
-3,512
-46% -$126K 0.02% 190
2020
Q3 		$248K Buy
+7,633
New +$229K 0.03% 195
2020
Q1 		– Sell
-7,923
Closed -$285K – 213
2019
Q4 		$285K Sell
7,923
-450
-5% -$15.5K 0.03% 175
2019
Q3 		$286K Sell
8,373
-1,606
-16% -$51.3K 0.04% 167
2019
Q2 		$279K Hold
9,979
– – 0.04% 172
2019
Q1 		$309K Sell
9,979
-115
-1% -$3.07K 0.04% 158
2018
Q4 		$239K Buy
10,094
+835
+9% +$22.8K 0.04% 171
2018
Q3 		$359K Buy
9,259
+569
+7% +$20.5K 0.05% 153
2018
Q2 		$291K Hold
8,690
– – 0.04% 165
2018
Q1 		$315K Sell
8,690
-901
-9% -$31.2K 0.05% 156
2017
Q4 		$305K Hold
9,591
– – 0.05% 156
2017
Q3 		$359K Buy
9,591
+130
+1% +$4.42K 0.05% 143
2017
Q2 		$295K Buy
9,461
+105
+1% +$3.03K 0.05% 158
2017
Q1 		$230K Buy
+9,356
New +$220K 0.03% 172

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Albion Financial Group's LMAT Position: Q1 2026 in Review

Albion Financial Group sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 2,624 shares — an estimated $213K sold.

Albion Financial Group first reported a position in LMAT in Q1 2017 and held it in 33 quarters. The position peaked at $359K in Q3 2018. 340 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Albion Financial Group reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Albion Financial Group sold 2,624 LeMaitre Vascular shares in Q1 2026, an estimated $213K.
  • Albion Financial Group first reported a position in LeMaitre Vascular in Q1 2017 and held it in 33 quarters.
  • Albion Financial Group's LeMaitre Vascular position peaked at $359K in Q3 2018.
  • 340 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Albion Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.